Chapel Hill, NC, United States of America

Michael Ross Johnson

USPTO Granted Patents = 170 (Patent Applications = 6)

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 7 (Patent Applications = 9)

Average Co-Inventor Count = 1.7

ph-index = 34

Forward Citations = 2,781(Granted Patents)

Inventors with similar research interests:

Location History:

New London, CT (US) (1976 - 1977)
Gales Ferry, CT (US) (1976 - 1990)
Groton, CT (US) (1982 - 1990)
Durham, NC (US) (2005 - 2017)
Chapel Hill, NC (US) (1990 - 2023)

Company Filing History:

Parion Sciences, Inc.

Years Active: 1976-2023

Loading Chart...

170 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11578042 - 3,5-diamino-6-chloro-N-(N-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide (2023-02-14),

2. 10968233 - Monothiol mucolytic agents (2021-04-06),

3. 10752597 - 3,5-diamino-6-chloro-N—(N-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide (2020-08-25),

4. 10526292 - Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases (2020-01-07),

5. 10526283 - Prodrugs of dithiol mucolytic agents (2020-01-07),

6. 10335558 - Methods of treatment (2019-07-02),

7. 10246425 - 3,5-diamino-6-chloro-N-(N-(4-phenylbutyl)carbamimidoyl) pyrazine-2-carboxamide compounds (2019-04-02),

8. 10233158 - Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds (2019-03-19),

9. 10167266 - Sodium channel blockers (2019-01-01),

10. 10159672 - Chemically and metabolically stable dipeptide possessing potent sodium channel blocker activity (2018-12-25),

11. 10106551 - Monothiol mucolytic agents (2018-10-23),

12. 10071970 - Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity (2018-09-11),

13. 9987443 - Inhaled hypertonic saline delivered by a heated nasal cannula (2018-06-05),

14. 9963427 - Dithiol mucolytic agents (2018-05-08),

15. 9957238 - Arylalkyl-and aryloxyalkyl-substituted epithelial sodium channel blocking compounds (2018-05-01),

Title: The Innovations of Inventor Michael Ross Johnson

Introduction

Michael Ross Johnson hails from Chapel Hill, NC (US) and is a prolific inventor with an impressive track record in the field of patents. With a total of 170 patents to his name, Johnson has made significant contributions to various industries through his innovative creations.

Latest Patents

Johnson's latest patents showcase his dedication to advancing healthcare solutions. One such invention is the compound 3,5-diamino-6-chloro-N-(N-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide. This compound, along with its pharmaceutically acceptable salts, is designed for promoting hydration of mucosal surfaces and treating diseases such as COPD, asthma, and pneumonia. Additionally, Johnson has developed monothiol mucolytic agents that offer innovative methods of treatment for various conditions.

Career Highlights

Throughout his career, Michael Ross Johnson has worked with esteemed companies such as Pfizer Corporation and Parion Sciences, Inc. His tenure at these organizations has allowed him to apply his expertise in research and development, leading to the creation of groundbreaking inventions that have a tangible impact on society.

Collaborations

Johnson has collaborated with industry experts like Lawrence S Melvin, Jr and Jasjit S Bindra. These partnerships have been instrumental in furthering the reach of his inventions and leveraging collective knowledge to push the boundaries of innovation in healthcare.

Conclusion

In conclusion, Michael Ross Johnson stands out as a pioneering inventor with a remarkable portfolio of patents. His relentless pursuit of novel solutions in the healthcare sector demonstrates his commitment to improving the lives of individuals affected by various respiratory conditions. Johnson's collaborative spirit and career achievements solidify his position as a trailblazer in the field of innovation.

This text is generated by artificial intelligence and may not be accurate.